Please note: This website includes an accessibility system. Press Control-F11 to adjust the website to the visually impaired who are using a screen reader; Press Control-F10 to open an accessibility menu.

Open accessibility options menu
  • 24/7
  • Buzz
  • Startups
  • VC
  • Finance@
  • Work@
  • Innovation
  • Opinions
  • Search
  • cleanSearch
  • Accesabillty
  • calcalist logo
bycalcalist logo
  • Homepage
  • Tags search
  • Multiple Sclerosis

CTech 24/7

    More stories in CTech

    Multiple Sclerosis

    2 stories about Multiple Sclerosis
    • Teva's U.S. headquarters. Photo: AP

      Mylan Cuts Price of Generic Copaxone Offering by 60%

      11.07.18|Lilach BaumerMylan has achieved a 15%-20% market share in the U.S. since launching its generic version in late 2017 with a monthly price tag of $5,000, compared to Teva's $5,800

    • Ehud Marom, co-founder of Mapi Pharme

      Former Teva Executive One Step Closer to Bringing Copaxone Rival to Market

      31.10.17|Lilach BaumerMapi Pharma announced a successful phase II clinical trial for its Copaxone equivalent GA Depot

    Load more
    Ctech Logo
    Twitter
    Twitter
    Facebook
    Facebook
    NewsLetter
    Newsletter
    Contact Us
    Contact Us
    Rss
    Rss
    About CTech Terms of Use Privacy Policy
    Developed by YIT UI & UX by Basch_Interactive